F&G Annuities & Life, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that F&G Annuities & Life, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.73B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.50B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.35B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $3.97B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.23B | Feb 27, 2023 |
| FY2022 | May 31, 2020 | $155.00M | Feb 27, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $639.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($58.00M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $635.00M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.24B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $136.00M | Feb 27, 2023 |
| FY2022 | May 31, 2020 | ($314.00M) | Feb 27, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.68B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.00B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.83B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.17B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.87B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $287.00M | Feb 27, 2023 |
| FY2022 | May 31, 2020 | ($224.00M) | Feb 27, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $98.43B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $84.93B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $70.20B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $54.63B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $48.73B | Feb 27, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.51B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $80.86B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $67.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $52.22B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $44.25B | Feb 27, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.80B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.95B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.41B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $5.03B | Feb 29, 2024 |
| FY2023 | Dec 31, 2020 | $4.07B | Feb 29, 2024 |
| FY2022 | May 31, 2020 | $2.74B | Feb 27, 2023 |
| FY2022 | Dec 31, 2019 | $2.59B | Feb 27, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.18B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.18B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.75B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.75B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.76B | Feb 27, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.57B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.44B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.93B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.06B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.00B | Feb 27, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.26B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.56B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $960.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.53B | Feb 27, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.17B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.75B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.11B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $977.00M | Feb 27, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 27, 2023 |
| FY2022 | May 31, 2020 | (1) | Feb 27, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 27, 2023 |
| FY2022 | May 31, 2020 | (1) | Feb 27, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 135.61M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 126.79M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 126.33M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | 126.41M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | 105.00M | Feb 28, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $101.00M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $0 | Feb 29, 2024 |